S. Soedamah-muthu, J. Fuller, H. Mulnier, V. Raleigh, R. Lawrenson et al., All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992???1999, Diabetologia, vol.20, issue.Suppl 2, pp.660-666, 1992.
DOI : 10.1007/s00125-005-0120-4

S. Seshasai, S. Kaptoge, A. Thompson, D. Angelantonio, E. Gao et al., Diabetes mellitus, fasting glucose, and risk of cause-specific death, N Engl J Med, vol.364, issue.9, pp.829-841, 2011.

T. Almdal, H. Scharling, J. Jensen, and H. Vestergaard, The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death, Archives of Internal Medicine, vol.164, issue.13, pp.1641422-1426, 2004.
DOI : 10.1001/archinte.164.13.1422

R. Pfister, D. Barnes, R. Luben, K. Khaw, N. Wareham et al., Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease, Diabetologia, vol.357, issue.Suppl 1, pp.2283-2287, 2011.
DOI : 10.1007/s00125-011-2206-5

F. Giacco and M. Brownlee, Oxidative Stress and Diabetic Complications, Circulation Research, vol.107, issue.9, pp.1058-1070, 2010.
DOI : 10.1161/CIRCRESAHA.110.223545

P. Stralin, K. Karlsson, B. Johansson, and S. Marklund, The Interstitium of the Human Arterial Wall Contains Very Large Amounts of Extracellular Superoxide Dismutase, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.15, issue.11, pp.2032-2036, 1995.
DOI : 10.1161/01.ATV.15.11.2032

U. Landmesser, R. Merten, S. Spiekermann, K. Buttner, H. Drexler et al., Vascular Extracellular Superoxide Dismutase Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Vasodilation, Circulation, vol.101, issue.19, pp.2264-2270, 2000.
DOI : 10.1161/01.CIR.101.19.2264

H. Takatsu, H. Tasaki, H. Kim, S. Ueda, M. Tsutsui et al., Overexpression of EC-SOD Suppresses Endothelial-Cell-Mediated LDL Oxidation, Biochemical and Biophysical Research Communications, vol.285, issue.1, pp.84-91, 2001.
DOI : 10.1006/bbrc.2001.5114

H. Kaneda, J. Taguchi, K. Ogasawara, T. Aizawa, and M. Ohno, Increased level of advanced oxidation protein products in patients with coronary artery disease, Atherosclerosis, vol.162, issue.1, pp.221-225, 2002.
DOI : 10.1016/S0021-9150(01)00706-7

R. Leleiko, C. Vaccari, S. Sola, N. Merchant, S. Nagamia et al., Usefulness of Elevations in Serum Choline and Free F2-Isoprostane to Predict 30-Day Cardiovascular Outcomes in Patients With Acute Coronary Syndrome, The American Journal of Cardiology, vol.104, issue.5, pp.638-643, 2009.
DOI : 10.1016/j.amjcard.2009.04.047

M. Marre, X. Jeunemaitre, Y. Gallois, M. Rodier, G. Chatellier et al., Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group, J Clin Invest, issue.7, pp.991585-1595, 1997.

S. Hadjadj, F. Pean, Y. Gallois, P. Passa, R. Aubert et al., Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy: The Genesis France-Belgium Study, Diabetes Care, vol.27, issue.11, pp.272661-2668, 2004.
DOI : 10.2337/diacare.27.11.2661

M. Marre, M. Lievre, G. Chatellier, J. Mann, P. Passa et al., Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study), BMJ, vol.328, issue.7438, p.328495, 2004.
DOI : 10.1136/bmj.37970.629537.0D

URL : https://hal.archives-ouvertes.fr/hal-00427520

K. Karlsson and S. Marklund, Plasma clearance of human extracellular-superoxide dismutase C in rabbits., Journal of Clinical Investigation, vol.82, issue.3, pp.762-766, 1988.
DOI : 10.1172/JCI113676

V. Witko-sarsat, M. Friedlander, C. Capeillere-blandin, T. Nguyen-khoa, A. Nguyen et al., Advanced oxidation protein products as a novel marker of oxidative stress in uremia, Kidney International, vol.49, issue.5, pp.491304-1313, 1996.
DOI : 10.1038/ki.1996.186

J. Sandstrom, P. Nilsson, K. Karlsson, and S. Marklund, 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain, J Biol Chem, vol.269, issue.29, pp.19163-19166, 1994.

D. Nyholt, A Simple Correction for Multiple Testing for Single-Nucleotide Polymorphisms in Linkage Disequilibrium with Each Other, The American Journal of Human Genetics, vol.74, issue.4, pp.765-769, 2004.
DOI : 10.1086/383251

B. Descamps-latscha, V. Witko-sarsat, T. Nguyen-khoa, A. Nguyen, V. Gausson et al., Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients, American Journal of Kidney Diseases, vol.45, issue.1, pp.39-47, 2005.
DOI : 10.1053/j.ajkd.2004.09.011

Y. Feng, C. Shen, G. Ma, J. Wang, Z. Chen et al., Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction, Heart and Vessels, vol.283, issue.1???2, pp.25374-378, 2010.
DOI : 10.1007/s00380-009-1220-8

A. Neves, K. Mohammedi, N. Emery, R. Roussel, F. Fumeron et al., Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects, Molecular Genetics and Metabolism, vol.106, issue.3, pp.359-365, 2012.
DOI : 10.1016/j.ymgme.2012.04.023

A. Mollsten, A. Jorsal, M. Lajer, N. Vionnet, and L. Tarnow, The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes, Diabetologia, vol.50, issue.12, pp.2590-2593, 2009.
DOI : 10.1007/s00125-009-1550-1

T. Adachi, H. Yamada, Y. Yamada, N. Morihara, N. Yamazaki et al., Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface, Biochemical Journal, vol.313, issue.1, pp.313235-239, 1996.
DOI : 10.1042/bj3130235

Y. Chu, A. Alwahdani, S. Iida, D. Lund, F. Faraci et al., Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant, Circulation, vol.112, issue.7, pp.1047-1053, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.531251

S. Marklund, P. Nilsson, K. Israelsson, I. Schampi, M. Peltonen et al., Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population, Journal of Internal Medicine, vol.242, issue.1, pp.5-14, 1997.
DOI : 10.1046/j.1365-2796.1997.00160.x

K. Juul, A. Tybjaerg-hansen, S. Marklund, N. Heegaard, R. Steffensen et al., Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk: The Copenhagen City Heart Study, Circulation, vol.109, issue.1, pp.59-65, 2004.
DOI : 10.1161/01.CIR.0000105720.28086.6C

C. Chang, K. Stankunas, C. Shang, S. Kao, K. Twu et al., Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tract, Development, vol.135, issue.21, pp.3577-3586, 2008.
DOI : 10.1242/dev.022350

C. Arrington, B. Dowse, S. Bleyl, and N. Bowles, Non-synonymous variants in pre-B cell leukemia homeobox (PBX) genes are associated with congenital heart defects, European Journal of Medical Genetics, vol.55, issue.4, pp.235-237
DOI : 10.1016/j.ejmg.2012.02.002

Y. Weng, D. Hsieh, W. Kuo, T. Lai, H. Hsu et al., E4BP4 is a cardiac survival factor and essential for embryonic heart development, Molecular and Cellular Biochemistry, vol.131, issue.1-2, pp.187-194, 2010.
DOI : 10.1007/s11010-010-0417-6

P. Libby, P. Ridker, and G. Hansson, Progress and challenges in translating the biology of atherosclerosis, Nature, vol.5, issue.7347, pp.317-325, 2011.
DOI : 10.1038/nature10146

Y. Higashi, K. Noma, M. Yoshizumi, and Y. Kihara, Endothelial Function and Oxidative Stress in Cardiovascular Diseases, Circulation Journal, vol.73, issue.3, pp.411-418, 2009.
DOI : 10.1253/circj.CJ-08-1102

H. Patel, J. Chen, K. Das, and M. Kavdia, Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC, Cardiovascular Diabetology, vol.12, issue.1, p.142, 2013.
DOI : 10.1186/1475-2840-12-142

F. Faraci and S. Didion, Vascular Protection: Superoxide Dismutase Isoforms in the Vessel Wall, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.8, pp.1367-1373, 2004.
DOI : 10.1161/01.ATV.0000133604.20182.cf

C. Rosa, N. Xavier, H. Campos, D. Fernandes, A. Cezar et al., Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats, Cardiovascular Diabetology, vol.12, issue.1, p.152
DOI : 10.1038/nprot.2008.138

E. Hopps, D. Noto, G. Caimi, and M. Averna, A novel component of the metabolic syndrome: The oxidative stress, Nutrition, Metabolism and Cardiovascular Diseases, vol.20, issue.1, pp.72-77, 2010.
DOI : 10.1016/j.numecd.2009.06.002

C. Heslop, J. Frohlich, and J. Hill, Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography, Journal of the American College of Cardiology, vol.55, issue.11, pp.551102-1109, 2010.
DOI : 10.1016/j.jacc.2009.11.050

A. Doney, S. Lee, G. Leese, A. Morris, and C. Palmer, Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta-Null Genotype: A Go-DARTS Study, Circulation, vol.111, issue.22, pp.1112927-2934, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.509224

L. Stull, M. Leppo, L. Szweda, W. Gao, and E. Marban, Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy, Circulation Research, vol.95, issue.10, pp.951005-1011, 2004.
DOI : 10.1161/01.RES.0000148635.73331.c5

S. Zhang, H. Liu, G. Amarsingh, C. Cheung, S. Hogl et al., Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation, Cardiovascular Diabetology, vol.13, issue.1, p.100, 2014.
DOI : 10.1186/1475-2840-13-100

T. Oury, B. Day, and J. Crapo, Extracellular superoxide dismutase in vessels and airways of humans and baboons, Free Radical Biology and Medicine, vol.20, issue.7, pp.957-965, 1996.
DOI : 10.1016/0891-5849(95)02222-8

E. Chen, H. Bittner, R. Davis, and R. Folz, Van Trigt P: Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts, Circulation, vol.94, issue.9, pp.412-417, 1996.

Q. Li, R. Bolli, Y. Qiu, X. Tang, Y. Guo et al., Gene Therapy With Extracellular Superoxide Dismutase Protects Conscious Rabbits Against Myocardial Infarction, Circulation, vol.103, issue.14, pp.1893-1898, 2001.
DOI : 10.1161/01.CIR.103.14.1893

M. Sentman, T. Brannstrom, S. Westerlund, M. Laukkanen, S. Yla-herttuala et al., Extracellular Superoxide Dismutase Deficiency and Atherosclerosis in Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.9, pp.1477-1482, 2001.
DOI : 10.1161/hq0901.094248

H. Sheng, T. Brady, R. Pearlstein, J. Crapo, and D. Warner, Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse, Neuroscience Letters, vol.267, issue.1, pp.13-16, 1999.
DOI : 10.1016/S0304-3940(99)00316-X

H. Sheng, R. Bart, T. Oury, R. Pearlstein, J. Crapo et al., Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia, Neuroscience, vol.88, issue.1, pp.185-191, 1999.
DOI : 10.1016/S0306-4522(98)00208-5